Prospective, Multicenter Study of the Efficacy and Tolerance of Tacrolimus on Refractory Nephrotic Syndrome (RNS)

PHASE3CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Kidney DiseasesNephrotic SyndromeTacrolimus
Interventions
DRUG

tacrolimus (FK506)

Started: 0.05-0.1mg/kg/d,divided into two daily dose at 12hr; the blood level:5-10ng/ml in induction phase;and 4-6ng/ml in maintenance phase;

All Listed Sponsors
lead

Sun Yat-sen University

OTHER

NCT00615667 - Prospective, Multicenter Study of the Efficacy and Tolerance of Tacrolimus on Refractory Nephrotic Syndrome (RNS) | Biotech Hunter | Biotech Hunter